The Evolution of n.c.a. 177Lu to n.c.a. 177Lu-Edotreotide for the Treatment of Neuroendocrine Tumours. Sixteen Years of Collaboration Between Zentralklinik Bad Berka and ITM
Crossref DOI link: https://doi.org/10.1007/978-3-031-33533-4_13
Published Online: 2024-01-06
Published Print: 2024
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harris, P.
Henkelmann, R.
Marx, S.
Zhernosekov, K.
Text and Data Mining valid from 2024-01-01
Version of Record valid from 2024-01-06
Chapter History
First Online: 6 January 2024